Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Limin Lin

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Water Research X|February 10, 2025
Comparative enrichment of complete ammonium oxidation bacteria in floccular sludge reactors: Sequencing batch reactor vs. continuous stirred tank reactorYing Zhu, Jiaying Hou, Fangang Meng, et al.
Nanoscale|May 27, 2026
Realizing ultra-multi-mode high-<i>Q</i> plasmonic resonances by extracting guided modes <i>via</i> metallic latticesLimin Lin, Shuang Qiu, Xuanyi Liu, et al.
Nanomaterials (Basel, Switzerland)|April 10, 2019
Compounding Plasmon⁻Exciton Strong Coupling System with Gold Nanofilm to Boost Rabi SplittingTingting Song, Zhanxu Chen, Wenbo Zhang, et al.
Oncotarget|May 26, 2018
A targeted transforming growth factor-beta (TGF-β) blocker, TTB, inhibits tumor growth and metastasisChanghua Zhou, Jing Li, Limin Lin, et al.
Molecular Therapy Oncolytics|April 26, 2019
Bp-Bs, a Novel T-cell Engaging Bispecific Antibody with Biparatopic Her2 Binding, Has Potent Anti-tumor ActivitiesJiayu Liu, Xiaoqiong Wu, Limin Lin, et al.
Steroids|January 15, 2019
Characterization of a highly specific monoclonal antibody against human aldo-keto reductase AKR1C3Jiayu Liu, Ping He, Limin Lin, et al.
Translational Oncology|February 19, 2018
A Single Domain-Based Anti-Her2 Antibody Has Potent Antitumor ActivitiesXiaoqiong Wu, Siqi Chen, Limin Lin, et al.
Marine Drugs|October 25, 2024
Revealing the Diversity of Sequences, Structures, and Targets of Peptides from South China Sea <i>Macrodactyla doreensis</i> Based on TranscriptomicsZiqiang Hua, Yanling Liao, Jinxing Fu, et al.
Frontiers in Pharmacology|June 26, 2026
Development of a stacking model for personalized treatment of Crohn's disease: leveraging routine clinical features to forecast infliximab responseShaojun Jiang, Limin Lin, Dan Yang, et al.
Plos One|January 23, 2018
Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cellsYumei Li, Changhua Zhou, Jing Li, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Water Research X|February 10, 2025
Comparative enrichment of complete ammonium oxidation bacteria in floccular sludge reactors: Sequencing batch reactor vs. continuous stirred tank reactorYing Zhu, Jiaying Hou, Fangang Meng, et al.
Nanoscale|May 27, 2026
Realizing ultra-multi-mode high-<i>Q</i> plasmonic resonances by extracting guided modes <i>via</i> metallic latticesLimin Lin, Shuang Qiu, Xuanyi Liu, et al.
Nanomaterials (Basel, Switzerland)|April 10, 2019
Compounding Plasmon⁻Exciton Strong Coupling System with Gold Nanofilm to Boost Rabi SplittingTingting Song, Zhanxu Chen, Wenbo Zhang, et al.
Oncotarget|May 26, 2018
A targeted transforming growth factor-beta (TGF-β) blocker, TTB, inhibits tumor growth and metastasisChanghua Zhou, Jing Li, Limin Lin, et al.
Molecular Therapy Oncolytics|April 26, 2019
Bp-Bs, a Novel T-cell Engaging Bispecific Antibody with Biparatopic Her2 Binding, Has Potent Anti-tumor ActivitiesJiayu Liu, Xiaoqiong Wu, Limin Lin, et al.
Steroids|January 15, 2019
Characterization of a highly specific monoclonal antibody against human aldo-keto reductase AKR1C3Jiayu Liu, Ping He, Limin Lin, et al.
Translational Oncology|February 19, 2018
A Single Domain-Based Anti-Her2 Antibody Has Potent Antitumor ActivitiesXiaoqiong Wu, Siqi Chen, Limin Lin, et al.
Marine Drugs|October 25, 2024
Revealing the Diversity of Sequences, Structures, and Targets of Peptides from South China Sea <i>Macrodactyla doreensis</i> Based on TranscriptomicsZiqiang Hua, Yanling Liao, Jinxing Fu, et al.
Frontiers in Pharmacology|June 26, 2026
Development of a stacking model for personalized treatment of Crohn's disease: leveraging routine clinical features to forecast infliximab responseShaojun Jiang, Limin Lin, Dan Yang, et al.
Plos One|January 23, 2018
Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cellsYumei Li, Changhua Zhou, Jing Li, et al.
Pageof 6